TTK Healthcare (BOM:507747) Operating Margin %: 4.08% (As of Mar. 2026) — 37% Above Median


BOM:507747 TTK Healthcare Ltd BOM:507747
72 GF Score
Price ₹923.35
GF Value ₹1,455.84
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is TTK Healthcare Operating Margin %?

TTK Healthcare BOM:507747 +0.47% 72 Operating Margin % is 4.08% as of Mar. 2026, which is 37% above its 10-year median of 2.98. GuruFocus rates BOM:507747 with a GF Score™ of 72/100 and a GF Value™ of ₹1,455.84 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 952 Drug Manufacturers companies, TTK Healthcare ranks worse than 65.23% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. TTK Healthcare's Operating Income for the three months ended in Mar. 2026 was ₹89 Mil. TTK Healthcare's Revenue for the three months ended in Mar. 2026 was ₹2,180 Mil. Therefore, TTK Healthcare's Operating Margin % for the quarter that ended in Mar. 2026 was 4.08%.

Good Sign:

TTK Healthcare Ltd operating margin is expanding. Margin expansion is usually a good sign.

The historical rank and industry rank for TTK Healthcare's Operating Margin % or its related term are showing as below:

BOM:507747' s Operating Margin % Range Over the Past 10 Years
Min: 1.4   Med: 2.98   Max: 5.77
Current: 2.03


BOM:507747's Operating Margin % is ranked worse than
65.23% of 952 companies
in the Drug Manufacturers industry
Industry Median: 7.58 vs BOM:507747: 2.03

TTK Healthcare's 5-Year Average Operating Margin % Growth Rate was 13.00% per year.

TTK Healthcare's Operating Income for the three months ended in Mar. 2026 was ₹89 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was ₹174 Mil.


TTK Healthcare  (BOM:507747) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


TTK Healthcare Operating Margin % Related Terms


TTK Healthcare Operating Margin % Historical Data

* Premium members only.

The historical data trend for TTK Healthcare's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TTK Healthcare Operating Margin % Chart

TTK Healthcare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.59 2.65 3.34 3.31 2.03

TTK Healthcare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.17 0.22 1.53 2.35 4.08

BOM:507747 vs LLY, JNJ, ABBV: Operating Margin % Comparison

For the Drug Manufacturers - General subindustry, TTK Healthcare's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TTK Healthcare Operating Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TTK Healthcare's Operating Margin % distribution charts can be found below:

* The bar in red indicates where TTK Healthcare's Operating Margin % falls into.


BOM:507747
72GF Score
TTK Healthcare Ltd BOM:507747
Operating Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TTK Healthcare Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

TTK Healthcare's Operating Margin % for the fiscal year that ended in Mar. 2026 is calculated as

Operating Margin %=Operating Income (A: Mar. 2026 ) / Revenue (A: Mar. 2026 )
=174.163 / 8572.811
=2.03 %

TTK Healthcare's Operating Margin % for the quarter that ended in Mar. 2026 is calculated as

Operating Margin %=Operating Income (Q: Mar. 2026 ) / Revenue (Q: Mar. 2026 )
=88.908 / 2179.847
=4.08 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of 4.08% mean?
TTK Healthcare (BOM:507747) has a Operating Margin % of 4.08% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on TTK Healthcare and its competitors. This is 37% above median its historical median of 2.98. Over the past decade, TTK Healthcare's Operating Margin % has ranged from 1.40 to 5.77. According to the industry distribution chart, TTK Healthcare ranks #621 out of 952 companies in the Drug Manufacturers industry, placing it in the top 65.2%.
Is TTK Healthcare's Operating Margin % too high?
TTK Healthcare's current Operating Margin % of 4.08% is 37% above median its 10-year median of 2.98. Over the past 10 years, this metric has ranged from a low of 1.40 to a high of 5.77. The Drug Manufacturers industry median Operating Margin % is 7.58. TTK Healthcare's value of 4.08% is 46.2% below this industry median. Based on the distribution chart, TTK Healthcare ranks #621 out of 952 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, TTK Healthcare has a GF Score™ of 72/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does TTK Healthcare's Operating Margin % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, TTK Healthcare ranks #621 out of 952 companies for Operating Margin %. This places TTK Healthcare in the lower half of its industry. The industry median Operating Margin % is 7.58. TTK Healthcare's value of 4.08% is 46.2% below this benchmark. Historically, TTK Healthcare's own Operating Margin % has ranged from 1.40 to 5.77 over the past decade. While the company's 10-year median is 2.98 vs. the industry median of 7.58, TTK Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Drug Manufacturers company?
The median Operating Margin % among Drug Manufacturers companies is 7.58, based on 952 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TTK Healthcare's current Operating Margin % of 4.08% is 46.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on TTK Healthcare and its competitors. For the Drug Manufacturers industry, the median Operating Margin % is 7.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TTK Healthcare's current Operating Margin % is 4.08%, which is 37% above median its own 10-year median of 2.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TTK Healthcare stock overvalued right now?
Based on GuruFocus' analysis, TTK Healthcare (BOM:507747) is currently considered Possible Value Trap. The stock's GF Value™ is ₹1,455.84, compared to a current price of ₹923.35 — trading 36.6% below its estimated fair value. The current Operating Margin % is 4.08%, which is 37% above median its 10-year median of 2.98 and 46.2% below the Drug Manufacturers industry median of 7.58. TTK Healthcare's overall GF Score™ is 72/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For TTK Healthcare (BOM:507747), the current Operating Margin % is 4.08% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TTK Healthcare (BOM:507747) Overvalued in 2026?

Based on GuruFocus' analysis, TTK Healthcare stock appears to be undervalued. The current stock price of ₹923.35 is trading 36.6% below its estimated GF Value™ of ₹1,455.84. GuruFocus considers TTK Healthcare to be Possible Value Trap.

Key valuation signals for BOM:507747:

  • Operating Margin %: 4.08% (37% above median its 10-year median of 2.98)
  • GF Value™: ₹1,455.84 vs. price of ₹923.35 (36.6% below fair value)
  • GF Score™: 72/100 with 2 warning signs
  • Industry Position: 46.2% below the Drug Manufacturers median (#621 of 952)

No single metric tells the full story. See the BOM:507747 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


TTK Healthcare Business Description

Other Exchanges TTKHLTCARE:India
Address No. 6, Cathedral Road, Chennai, TN, IND, 600 086
TTK Healthcare Ltd is an Indian pharmaceutical company. The company's operating segment includes Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods Division, and Others. Its Animal Welfare segment includes products for both Human and Veterinary use. The Consumer Products comprises of marketing and distribution of Woodwards's Gripe Water, EVA Range of Cosmetics, Good Home range of Scrubbers, Air Fresheners and others. Protective Devices comprises of manufacturing and marketing of Male Contraceptives and other allied products. It generates maximum revenue from the Pharmaceuticals segment. Geographically, it derives a majority of revenue from India.
72GF Score

Get the complete analysis for BOM:507747

Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹923.35
Price
₹1,455.84
GF Value